Article (Périodiques scientifiques)
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
Battelino, T.; Conget, I.; Olsen, B. et al.
2012In Diabetologia, 55 (12), p. 3155-3162
Peer reviewed vérifié par ORBi
 

Documents


Texte intégral
battelino et al. 2012 switch continuous glucose monitoring.pdf
Postprint Éditeur (204.47 kB)
Télécharger

Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
continuous glucose monitoring; diabetes mellitus type 1; glycaemic control; insulin pump therapy; randomised controlled trial; sensor-augmented insulin pump therapy
Résumé :
[en] Aims/hypothesis The aim of this multicentre, randomised, controlled crossover study was to determine the efficacy of adding continuous glucose monitoring (CGM) to insulin pump therapy (CSII) in type 1 diabetes. Methods Children and adults (n = 153) on CSII with HbA1c 7.5–9.5% (58.5–80.3 mmol/mol) were randomised to (CGM) a Sensor On or Sensor Off arm for 6 months. After 4 months’ washout, participants crossed over to the other arm for 6 months. Paediatric and adult participants were separately electronically randomised through the case report form according to a predefined randomisation sequence in eight secondary and tertiary centres. The primary outcome was the difference in HbA1c levels between arms after 6 months. Results Seventy-seven participants were randomised to the On/Off sequence and 76 to the Off/On sequence; all were included in the primary analysis. The mean difference in HbA1c was –0.43% (–4.74 mmol/mol) in favour of the Sensor On arm (8.04% [64.34 mmol/mol] vs 8.47% [69.08 mmol/mol]; 95% CI −0.32%, −0.55% [−3.50, −6.01 mmol/mol]; p < 0.001). Following cessation of glucose sensing, HbA1c reverted to baseline levels. Less time was spent with sensor glucose <3.9 mmol/l during the Sensor On arm than in the Sensor Off arm (19 vs 31 min/day; p = 0.009). The mean number of daily boluses increased in the Sensor On arm (6.8 ± 2.5 vs 5.8 ± 1.9, p < 0.0001), together with the frequency of use of the temporary basal rate (0.75 ± 1.11 vs 0.26 ± 0.47, p < 0.0001) and manual insulin suspend (0.91 ± 1.25 vs 0.70 ± 0.75, p < 0.018) functions. Four vs two events of severe hypoglycaemia occurred in the Sensor On and Sensor Off arm, respectively (p = 0.40). Conclusions/interpretation Continuous glucose monitoring was associated with decreased HbA1c levels and time spent in hypoglycaemia in individuals with type 1 diabetes using CSII. More frequent self-adjustments of insulin therapy may have contributed to these effects.
Disciplines :
Sciences de la santé humaine: Multidisciplinaire, généralités & autres
Auteur, co-auteur :
Battelino, T.
Conget, I.
Olsen, B.
Schütz-Fuhrmann, I.
Hommel, E.
Hoogma, R.
Schierloh, U.
Sulli, N.
Bolinder, J.
DE BEAUFORT, Carine ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
Date de publication/diffusion :
décembre 2012
Titre du périodique :
Diabetologia
ISSN :
0012-186X
eISSN :
1432-0428
Maison d'édition :
Springer Verlag, Berlin, Allemagne
Volume/Tome :
55
Fascicule/Saison :
12
Pagination :
3155-3162
Peer reviewed :
Peer reviewed vérifié par ORBi
Intitulé du projet de recherche :
SWITCH study group
Disponible sur ORBilu :
depuis le 30 avril 2016

Statistiques


Nombre de vues
186 (dont 0 Unilu)
Nombre de téléchargements
217 (dont 0 Unilu)

citations Scopus®
 
458
citations Scopus®
sans auto-citations
417
OpenCitations
 
368
citations OpenAlex
 
481
citations WoS
 
367

Bibliographie


Publications similaires



Contacter ORBilu